FXR Antibodies

Santa Cruz Biotechnology features a diverse variety of FXR Antibodies for research focused on understanding the farnesoid X receptor (FXR) in various biological processes. Monoclonal FXR Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The farnesoid X receptor is a nuclear receptor that plays a crucial role in bile acid homeostasis, lipid metabolism, and glucose regulation. FXR is actively involved in modulating inflammatory responses and has been linked to metabolic diseases, making it a significant target for therapeutic interventions. Understanding FXR function is essential for advancing research in liver diseases, obesity, and diabetes. Researchers worldwide rely on FXR detection methods to explore cellular pathways and molecular mechanisms. Current studies of FXR continue to reveal new insights into metabolic regulation and potential therapeutic approaches. Ongoing research with FXR has highlighted its importance in maintaining cellular homeostasis and tissue function. Santa Cruz Biotechnology monoclonal FXR Antibodies enable researchers to advance scientific understanding of metabolic diseases and potential treatments.